Patients and clinicians should rely on FDA-approved medications whenever possible, as these products have undergone full safety, efficacy, and quality review
Patano N, Mancini L, Settanni MP, Strippoli M, Brunetti G, Greco G, Tamma R, Vergari R, Sardelli F, Koverech A, Colucci S, Zallone A, Grano M: L: -carnitine fumarate and isovaleryl-L: -carnitine fumarate accelerate the recovery of bone volume/total volume ratio after experimetally induced osteoporosis in pregnant mice
Notably, there is an FDA proposal to exclude certain active ingredients in Novo's products from the mass compounding list
LUPKIN: Thats Josh Fritzler, the chief financial officer for Olympia Pharmaceuticals, a large compounding pharmacy in Orlando, Florida